Last reviewed · How we verify
Reinovax PCV24 formulation 2
At a glance
| Generic name | Reinovax PCV24 formulation 2 |
|---|---|
| Sponsor | Shanghai Reinovax Biologics Co.,LTD |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (PHASE2)
- Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |